Clinical Trial Update: A Protocol of Irinotecan for Carcinoma of the Lung [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of irinotecan for lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Susanne Arnold | Conditions: Lung Cancer | Phase 2 | Status: WITHDRAWN